These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Jun 23, 2021
Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, granted a stock option to a new employee as approved...
Jun 21, 2021
—Topline data anticipated in Q1 2022 with NDA filing to follow in H2 2022— SAN MATEO, Calif., June 21, 2021 /CNW/ - Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company...
Jun 14, 2021
--Chief Medical Officer Dr. Barbara Klencke, to be joined by leading myelofibrosis experts Drs. Aaron Gerds, Stephen Oh and Srdan Verstovsek-- SAN MATEO, Calif., June 14, 2021 /CNW/ - Sierra...
Jun 11, 2021Momelotinib Oral Presentation at European Hematology Association Demonstrates Association Between Transfusion Independence and Improved Overall Survival
—Additional poster presentation highlights improved transfusion independence of momelotinib irrespective of baseline degree of anemia, platelet count or transfusion status— SAN MATEO, Calif.,...
Jun 3, 2021
—Georgia Erbez and Christy Oliger bring additional strategy, finance and commercial experience as Sierra prepares for commercialization of momelotinib— SAN MATEO, Calif., June 3, 2021 /CNW/ -...